ScholarLens Back to search
2013•The Lancet OncologyRequires access

Inhibition of HSP90 molecular chaperones: moving into the clinic

Rocio García‐Carbonero, Amancio Carnero, Luis Paz‐Ares

Open publisher page 355 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 355 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Hsp90, Geldanamycin, CDC37, Hsp90 inhibitor, Proteasome, Heat shock protein, Cancer research, Cell cycle

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Inhibition of HSP90 molecular chaperones: moving into the clinic — Research Paper | ScholarLens